What Is the Life Expectancy and Survival Rate for Trisomy 18?
At a Glance
Trisomy 18 is life-limiting, but survival varies widely. Most live-born infants die in infancy; about 12% to 13% reach age one and 8% to 10% reach age ten in population studies. Genetic subtype, heart and breathing problems, digestive anomalies, and individualized care shape the outlook.
In this answer
5 sections
The diagnosis of trisomy 18 (Edwards syndrome) brings urgent and frightening questions about the future. For decades, parents were often told that this condition is universally “incompatible with life.” Today, medical literature shows a more nuanced reality: while trisomy 18 is a life-limiting condition with a high rate of infant mortality, some children with trisomy 18 survive into childhood, and rarely, into adolescence or adulthood [1][2].
Because outcomes vary drastically based on genetic subtypes, anatomical complications, and a family’s care goals, population statistics can only describe broad trends. They cannot predict the exact life expectancy for your individual child.
Survival Rates Across Different Stages
When reviewing survival statistics, it is important to look at studies as distinct snapshots in time rather than a single continuous timeline. Different studies cover different eras, countries, and medical practices, so their numbers cannot be perfectly lined up as a single countdown.
Prenatal Diagnosis
For pregnancies where trisomy 18 is detected, a large percentage do not result in a live birth due to miscarriage, stillbirth, or pregnancy termination. A meta-analysis estimated that roughly 48% of prenatally diagnosed cases resulted in a live birth [3]. Studies show that the later in pregnancy a diagnosis is made, the higher the observed rate of live birth [4]. However, this is largely a selection effect—those pregnancies have already naturally survived longer, rather than the passage of time itself improving a baby’s biological chances.
Infancy and Childhood
For live-born infants, large population-based registries offer comprehensive estimates of survival. Note that these cohorts come from different geographic regions and timeframes:
- One Month (Neonatal): In a large European registry of babies born between 1995 and 2014, approximately 38% of live-born infants survived to 28 days [1].
- One Year: The same European registry, along with a population study in Ontario, Canada, estimated that 12% to 13% of infants survived to their first birthday [1][5].
- Early Childhood (5 Years): A separate multi-state study in the US (following babies born between 1999 and 2007) found a 12.3% survival rate at age five [6]. Because this is a different study from the registries mentioned above, the similar percentage does not mean children stop dying between ages one and five.
- Older Childhood (10 Years): European and Canadian registries estimate that between 8% and 10% of children with trisomy 18 reach age ten [1][5].
Survival conditional on reaching a certain age is different than survival measured from birth. For example, in the European study, of the infants who survived their first four weeks, 21% went on to reach age ten [1].
How the Type of Trisomy 18 Affects Survival
The genetic subtype of trisomy 18 significantly impacts life expectancy.
- Full Trisomy 18: An extra chromosome 18 is found in essentially all cells tested. This is the most common form. A Texas population registry reported a 10-year survival rate of 6.6% for this group [7].
- Mosaic and Partial Trisomy 18: In mosaic trisomy 18, only a percentage of cells have the extra chromosome. In partial trisomy 18, only a segment of the chromosome is duplicated. These forms often present with less severe medical complications. The Texas registry found a combined 10-year survival rate of 43.8% for mosaic and partial cases, though this was a small, combined group and should not be used as a guaranteed individual prognosis [7]. Furthermore, blood tests cannot always determine how heavily mosaicism affects specific internal organs [8].
The Impact of Medical Intervention and Palliative Care
In actively managed hospital settings, survival rates are often higher. For example, one Japanese tertiary center reported a one-year survival rate of over 59% for its patients [9].
However, understanding these numbers requires acknowledging selection bias—infants who are offered cardiac or gastrointestinal surgeries are often those deemed structurally strong enough to survive the procedure, meaning they may already have had a biological survival advantage [10][11]. While a pooled analysis of observational studies did not find a statistically significant one-year survival difference between intensive care and non-intensive care groups, this does not mean active treatments are entirely ineffective [12]. It simply means current data cannot perfectly separate the benefit of a treatment from the underlying health of the infant selected for it. Specific surgeries can improve survival to hospital discharge for selected infants, though they do not cure the underlying genetic condition [13].
Importantly, families do not have to choose strictly between intensive intervention and “giving up.” Pediatric palliative care is an active medical specialty focused on maximizing a child’s comfort and quality of life [14]. It can include oxygen, feeding support, and pain management, and can be provided alongside intensive, disease-directed treatments or as part of a comfort-focused care plan [14][15]. Care plans are not locked in; they can be revised as your baby’s condition and your family’s priorities evolve.
Common Serious Complications
Life expectancy is heavily influenced by the specific physical complications a child is born with:
- Respiratory Issues: Breathing problems and sleep apnea are common. Among infants who die before 30 days of age, respiratory failure is the most frequent cause [16].
- Congenital Heart Disease: Structural heart defects are extremely common. These often include ventricular septal defects (VSD) (a hole between the lower heart chambers), atrial septal defects (ASD) (a hole between the upper chambers), and a patent ductus arteriosus (PDA) (an unclosed blood vessel) [17]. Heart failure is the predominant cause of death for infants who survive beyond their first month [16].
- Feeding and Digestive Anomalies: Challenges with safe swallowing or conditions like esophageal atresia (where the swallowing tube does not connect properly to the stomach) can heavily impact health and require significant medical support [18][19].
Looking Beyond the Numbers
Long-term survivors with trisomy 18 generally experience developmental disability and a wide range of support needs, often utilizing medical technologies like feeding tubes or oxygen [2]. However, many families report meaningful interaction and quality of life. The statistics are meant to inform your conversations with your care team, not to define your child’s value or dictate the only path your family must take.
Common questions in this guide
How long do babies with trisomy 18 usually live?
What is the 10-year survival rate for trisomy 18?
Does mosaic or partial trisomy 18 usually have better survival?
Can surgery or other treatment improve survival in trisomy 18?
What does palliative care mean for a baby with trisomy 18?
Which medical problems most affect survival in trisomy 18?
Related questions
Show more
Get notified when new evidence is published on Trisomy 18 syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Ten-year survival of children with trisomy 13 or trisomy 18: a multi-registry European cohort study.
Glinianaia SV, Rankin J, Tan J, et al.
Archives of disease in childhood 2023; (108(6)):461-467 doi:10.1136/archdischild-2022-325068.
PMID: 36882305 - 2
Liveborn children with trisomy 18: A retrospective review.
Armour E, MacPherson MJ, Mack C, et al.
Paediatrics & child health 2025; (30(3)):164-170 doi:10.1093/pch/pxae097.
PMID: 40599664 - 3
Parental counseling in trisomy 18: Novel insights in prenatal features and postnatal survival.
Russo FM, Pozzi E, Verderio M, et al.
American journal of medical genetics. Part A 2016; (170A(2)):329-336 doi:10.1002/ajmg.a.37424.
PMID: 26473304 - 4
Revised estimates of the risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18.
Cavadino A, Morris JK
American journal of medical genetics. Part A 2017; (173(4)):953-958 doi:10.1002/ajmg.a.38123.
PMID: 28328132 - 5
Survival and Surgical Interventions for Children With Trisomy 13 and 18.
Nelson KE, Rosella LC, Mahant S, Guttmann A
JAMA 2016; (316(4)):420-8 doi:10.1001/jama.2016.9819.
PMID: 27458947 - 6
Survival of children with trisomy 13 and trisomy 18: A multi-state population-based study.
Meyer RE, Liu G, Gilboa SM, et al.
American journal of medical genetics. Part A 2016; (170A(4)):825-37 doi:10.1002/ajmg.a.37495.
PMID: 26663415 - 7
Long-Term Survival Among Children With Trisomy 13 and Trisomy 18 by Cytogenetic Status.
Ludorf KL, Benjamin RH, Shumate CJ, et al.
JAMA network open 2025; (8(9)):e2529885 doi:10.1001/jamanetworkopen.2025.29885.
PMID: 40920381 - 8
Phenotypic Spectrum of Trisomy 18 Mosaicism: a New Patient and Literature Review.
Sun W, Wang L, Liu T, et al.
Clinical laboratory 2023; (69(3)) doi:10.7754/Clin.Lab.2022.220610.
PMID: 36912299 - 9
Improving survival in patients with trisomy 18.
Tamaki S, Iwatani S, Izumi A, et al.
American journal of medical genetics. Part A 2022; (188(4)):1048-1055 doi:10.1002/ajmg.a.62605.
PMID: 34889030 - 10
Poorer survival in prenatally diagnosed trisomy 18 infants compared with postnatally diagnosed cases: a single-center study.
Koshida S, Takahashi K
PeerJ 2026; (14()):e21515 doi:10.7717/peerj.21515.
PMID: 42437037 - 11
Treatment courses and outcomes of oesophageal atresia in patients with trisomy 18: a case series of 271 patients from a nationwide database in Japan.
Kutsukake M, Konishi T, Fujiogi M, et al.
Archives of disease in childhood. Fetal and neonatal edition 2024; (109(3)):336-341 doi:10.1136/archdischild-2023-326354.
PMID: 38071520 - 12
Intensive versus comfort-focused care in neonates with trisomy 18: A systematic review and meta-analysis.
Fonseca Queiroz L, Lemos MJ, Curi-Pesantes B, et al.
Journal of neonatal-perinatal medicine 2026; 19345798261490120 doi:10.1177/19345798261490120.
PMID: 42746679 - 13
Outcomes of heart surgery in neonates with trisomy 13 and 18: a systematic review with metanalysis.
de Sá Bittencourt Câmara Bastos C, Vale da Cruz L, Hirano Arruda Moraes L, et al.
European journal of pediatrics 2025; (184(7)):430 doi:10.1007/s00431-025-06274-7.
PMID: 40537699 - 14
Cardiac Interventions for Patients With Trisomy 13 and Trisomy 18: Experience, Ethical Issues, Communication, and the Case for Individualized Family-Centered Care.
Cleary JP, Janvier A, Farlow B, et al.
World journal for pediatric & congenital heart surgery 2022; (13(1)):72-76 doi:10.1177/21501351211044132.
PMID: 34919485 - 15
Trisomy 18-when the diagnosis is compatible with life.
Silva C, Ferreira MC, Saraiva J, Cancelinha C
European journal of pediatrics 2022; (181(7)):2809-2819 doi:10.1007/s00431-022-04477-w.
PMID: 35522316 - 16
Differences in mortality and morbidity according to gestational ages and birth weights in infants with trisomy 18.
Imai K, Uchiyama A, Okamura T, et al.
American journal of medical genetics. Part A 2015; (167A(11)):2610-7 doi:10.1002/ajmg.a.37246.
PMID: 26307940 - 17
An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18.
Bruns DA, Martinez A
American journal of medical genetics. Part A 2016; (170A(2)):337-343 doi:10.1002/ajmg.a.37427.
PMID: 26453443 - 18
Causes of death in individuals with trisomy 18 after the first year of life.
Mehl JM, Gelfond J, Carey JC, Cody JD
American journal of medical genetics. Part A 2024; (194(2)):279-287 doi:10.1002/ajmg.a.63436.
PMID: 37822198 - 19
Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011.
Springett A, Wellesley D, Greenlees R, et al.
American journal of medical genetics. Part A 2015; (167A(12)):3062-9 doi:10.1002/ajmg.a.37355.
PMID: 26347425
This page is for informational purposes only and does not constitute medical advice. Trisomy 18 survival statistics cannot predict an individual child's outcome; discuss your child's diagnosis, care options, and prognosis with the medical team.